SCHEMBL18355180

SCHEMBL18355180

CC(C)(C)[Si](C)(C)O[C@H]1Cc2ccccc2C1n1cc(C=O)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16835035 1.00 — —
SCHEMBL18355210 0.82 ACHE (0.31) —
SCHEMBL18355084 0.82 OGA (0.34) —
SCHEMBL22417213 0.82 ALKBH2 (0.35) —
SCHEMBL16835234 0.82 P2RX7 (0.33) —
SCHEMBL16835233 0.82 P2RX7 (0.33) —
SCHEMBL16835093 0.82 ALKBH2 (0.35) —
SCHEMBL18355083 0.82 OGA (0.34) —
SCHEMBL20193899 0.78 OGA (0.41) —
SCHEMBL22394435 0.78 OGA (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9981942-B2 Piperidine derivatives having multimodal activity against pain LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2018-05-29 — — US disclosed
US-20170001978-A1 PIPERIDINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2017-01-05 — — US disclosed
Send feedback